Crossmark

Pilot Interventional Study Comparing Fetomaternal Outcomes of 150 mg Versus 75 mg Aspirin Starting Between 11 and 14 Weeks of Pregnancy in Patients with High Risk of Preeclampsia: A Randomized Control Trial

Crossref DOI link: https://doi.org/10.1007/s13224-019-01277-5

Published Online: 2019-09-20

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kumar, Namrata

Das, Vinita

Agarwal, Anjoo

Pandey, Amita

Agrawal, Smriti

Singh, Amrita
Funding

Funding for this research was provided by:

Research cell, King Georges Medical University (1125/R cell-16)
License Information

Text and Data Mining valid from 2019-09-20

Version of Record valid from 2019-09-20
More Information

Article History

Received: 2 April 2019

Accepted: 9 September 2019

First Online: 20 September 2019

Compliance with Ethical Standards

:

: There is no conflict of interest among the authors. There is no financial relationship with any organization.

: All procedures followed were in accordance with the ethical standards of the responsible Institutional Committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008 (5).

: Informed consent was obtained from all patients for being included in the study.

Document is current

Any future updates will be listed below